The three envelope proteins of the hepatitis B virus (HBV) are encoded by a single open reading frame in the genome containing three separate in-phase AUG codons. This organization defines three protein domains (pre-S1, pre-S2, S) which form the small (S), middle (M, pre-S2/S), and large (L, pre-S1/pre-S2/S) proteins. Mature virions are generated by the budding of preformed nucleocapsids through endoplasmic reticulum (ER) membranes containing S and L proteins, whereas the M protein is not necessary. This suggests an important function for the pre-S1 domain. To investigate the protein-protein interactions involved during the maturation process of the HBV virion, we studied in vitro the binding affinity to purified HBV core particles of various synthetic peptides identical to regions of the envelope proteins. Data previously obtained with deletion mutants were confirmed and refined. The 13 C-terminal amino acids of pre-S1 bound efficiently to core particles, whereas other pre-S domains did not. Moreover, the amino acid sequence 56-80 in the cytosolic loop of S bound efficiently to the HBV core. This double interaction between the HBV capside and both S and pre-S1 domains may be required for virion morphogenesis. ᭧ 1997 Academic Press Hepatitis B virus (HBV) is an enveloped DNA virus of major constituent of both virion and empty particle envelopes (6). L protein is necessary for virion maturation, the Hepadnavirus family which causes a variety of acute and chronic liver diseases in humans (reviewed in Ref. 1 and S is required but not sufficient (3, 7, 8) . M seems to be dispensable (3, 7). S protein is unique among viral and 2). Its genome is encapsidated with a virus-encoded envelope proteins in its capacity to self-assemble with polymerase in a 27-nm diameter nucleocapsid surhost-derived lipids into secreted empty envelope partirounded by a host-derived lipid envelope bearing three cles (9). It has a type I signal at its N terminus and an viral surface proteins. The mature 42-nm virion is formed internal type II signal which result in the protein to traby a preformed cytosolic nucleocapsid interacting with verse the membrane at least twice and form a cytosolic surface proteins anchored in a pre-Golgi membrane and loop and a luminal domain (reviewed in Ref. 10). The Cis secreted by the constitutive secretory pathway (3-5).
Hepatitis B virus (HBV) is an enveloped DNA virus of major constituent of both virion and empty particle envelopes (6) . L protein is necessary for virion maturation, the Hepadnavirus family which causes a variety of acute and chronic liver diseases in humans (reviewed in Ref. 1 and S is required but not sufficient (3, 7, 8) . M seems to be dispensable (3, 7) . S protein is unique among viral and 2). Its genome is encapsidated with a virus-encoded envelope proteins in its capacity to self-assemble with polymerase in a 27-nm diameter nucleocapsid surhost-derived lipids into secreted empty envelope partirounded by a host-derived lipid envelope bearing three cles (9) . It has a type I signal at its N terminus and an viral surface proteins. The mature 42-nm virion is formed internal type II signal which result in the protein to traby a preformed cytosolic nucleocapsid interacting with verse the membrane at least twice and form a cytosolic surface proteins anchored in a pre-Golgi membrane and loop and a luminal domain (reviewed in Ref. 10) . The Cis secreted by the constitutive secretory pathway (3) (4) (5) .
terminus of S is very hydrophobic and is believed to be The three HBV surface proteins are translated from a embedded in the lipid bilayer ( Fig. 1 ). L protein can adopt single open reading frame of the viral genome from three two different trans-membrane topologies (11-13). The different in-phase start codons. Therefore the 226 amino first called e-pre-S has pre-S domains on the luminal acid sequence of the small (S) protein is repeated at the side of the ER. After budding, pre-S domains become C termini of the middle (M) and the large (L) surface exposed on the surface of secreted virions and capable proteins, which carry the additional N-terminal 55 amino of binding to a virus receptor (14) . The second called iacid pre-S2 domain and the 163 amino acid (subtypes pre-S has the pre-S domain on the cytosolic side of the ayw) pre-S2 plus pre-S1 domain, respectively (6) . In addi-ER ( Fig. 1 ) thus providing a specific interaction with HBV tion to the virion, HBV surface proteins can also be indenuceocapsid during virion assembly (7). This specific inpendently secreted from cells as 22-nm diameter spheriteraction has been investigated by testing the ability of cal or tubular subviral particles. These empty particles various truncated L mutants to form virions. Thus, the 17 are found at much higher serum concentrations than C-terminal amino acids of the pre-S1 domain (aa 91 to virions and consist of host lipids and viral envelope pro-108 in the ayw subtype) are essential for virion formation, teins without any other viral component. S protein is the whereas the N-terminal 5/6 of the pre-S1 sequence are not required for this process (7). The S protein is also necessary for virion maturation but its exact function has 1 To whom correspondence and reprint requests should be addressed. Fax: (33) 2 47 36 60 90. E-mail: Roingeard@univ-tours.fr. not been determined. It is unclear whether S interacts 115 0042-6822/97 $25.00
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the first 10 aa of peptide L4) and peptide 4b (the last 13 aa of peptide L4 plus the first 8 peptides of pre-S2) (Fig.  1) . All peptides were synthesized with an automated peptide synthesizer (Applied Biosystems 431A) by the solidphase procedure developed by Merrifield (16) , with 9-fluorenyl-methoxycarbonyl-protected amino acids and phydroxymethyl-phenoxyacetic resin. After synthesis, the resin support and the side chain-protecting groups were removed by treatment with trifluoroacetic acid in the presence of scavengers. Peptides were purified by reverse-phase chromatography on C8 columns (Aquapore octyl; 20 mm; 100 by 10 mm; Applied Biosystems) and characterized by amino acid analysis (17) . Purification of HBV core particles: Human HBcAg-positive tissue obtained from a liver necropsy was homogenized in a gentle lysis buffer (10 mM Tris-HCl, pH 7.2, 150 mM NaCl, 0.1 mM EDTA, 0.1% NP-40, 0.05% 2 bmercaptoethanol). Cell fragments were removed by centrifugation at 10,000 rpm for 30 min at 4ЊC. The supernatant was spun on a isopycnic 24 to 64% sucrose gradient (wt/vol in 150 mM NaCl, 20 mM Tris-HCl, pH 7.4) at 22,000 rpm for 36 hr in a SW 28 swinging rotor (Beckman, Somerset, NJ). Fractions were tested for the presence of HBV core particles by HBcAg-specific enzyme-linked immunoassay (ELISA) as described elsewhere (18) . the washing buffer. Fractions were diluted 1/500 in a dilution buffer [PBS containing 0.05% Tween and 2% milk powder] then added to the wells and incubated for 3 hr with L, with the HBV core or with both during particle at 37Њ. After four washes, the plates were incubated for assembly. In this work, pre-S1, pre-S2, and the cytosolic 1 hr at 37Њ with the monoclonal anti-HBc antibody 6C6A1 loop of S were mapped in synthetic peptides which were (18) diluted 1/1000 in the dilution buffer, then washed tested for their ability to bind purified liver-derived HBV four times and incubated for 1 hr at 37Њ with peroxidasecore particles.
conjugated goat anti-mouse IgG (Cappel, West Chester, S and L peptides synthesis: Peptides corresponding PA) diluted 1/2000 in dilution buffer. After four washes, to pre-S1, pre-S2, and the cytosolic loop of S were synthethe peroxidase reaction was performed by adding a mixsized as shown in Fig. 1 . The amino acid sequence was ture of hydrogen peroxide/o-phenylenediamine substrate obtained from the Swiss-prot database (AC P03138), cor-(Sigma, St-Louis, MO) and incubating for 30 min in the responding to the ayw subtype DNA sequence published dark. The reaction was stopped with 4 N H 2 SO 4 and by Galibert et al. (15) . The cytosolic loop of S was covered the optical density at 492 nm was determined with a by two 25 amino acid peptides, S1 and S2. The pre-S1 microplate reader. domain was covered by four peptides of 28, 28, 29, and HBc Ag-positive fractions were pooled, dialyzed 23 amino acids named L1, L2, L3, and L4, respectively. against 25 mM Tris-HCl, pH 8.5, 50 mM NaCl, and the Pre-S2 was covered by a single 55 amino acids peptide, preparation was further purified by a ion-exchange chro-L5. Two additional peptides overlapping peptide L4 were matography on a DEAE-trysacryl M gel (LKB, Bromma, Sweden 
To obtain a reproducible optical density value of 2.5 dilutions by ELISA as described above (Fig. 2) . Fractions 30 to 37 were pooled and concentrated 10-fold by centrifin control wells (without peptide), the assay was slightly modified as follows. Human anti-HBc IgG diluted 1/500 ugation at 25,000 rpm for 6 hr (4Њ, rotor SW 28, Beckman). This final core particle preparation contained 0.4 mg/ml dilution in 50 mM bicarbonate buffer, pH 9.6, were coated onto polystyrene plates (Maxisorp, Nunc, Naperville, IL), of protein and the specific activity measured with 1/2 serial dilutions by HBcAg ELISA was 2 8 per mg of protein.
for 20 hr at 4Њ (100 ml per well). The HBV core preparation was diluted 1/100 in 1 mM PBS, 15 mM NaCl, pH 7.4, HBV core particles of 28 to 32 nm diameter were observed by electron microscopy (Jeol 1200 EX, Tokyo) after and incubated for 20 hr at 4Њ with each of a series of concentrations (0 to 100 mg/ml) of each peptide in the negative staining with 2% uranyl acetate. same buffer. Plates were washed three times with 0.01 washed three times with 0.01 M PBS, 0.15 M NaCl, pH 7.4, containing 0.5% Tween 20, and blocked by the addition of M PBS, 0.15 M NaCl, pH 7.4, containing 0.5% Tween 20 and blocked by the addition of 300 ml of PBS containing 300 ml of PBS containing 2% newborn calf serum (NBCS) incubated for 45 min at 37Њ. After one wash, the HBV core 2% newborn calf serum (NBCS) incubated for 45 min at 37Њ. The mixed core particles/peptide preparations were preparation diluted 1/50 in 1 mM PBS, 15 mM NaCl, pH 7.4, was incubated for 24 hr at 4Њ. The other steps for core then added to the wells and incubated for 1 hr at room temperature. After three washes, 100 ml of monoclonal particles detection (monoclonal anti-HBc and peroxidaseconjugated goat anti-mouse incubations) were performed anti-HBc 6C6A1 diluted 1/10,000 in 0.05 M PBS, 0.75 M NaCl, pH 7.4, containing 5% NBCS, 5% bovine serum as above. The cut-off value was choosen as twofold the mean value obtained from nine control wells containing albumin (BSA), and 0.5% Tween 20, was added and incubated for 1 hr at room temperature. Following three BSA alone (2 1 0.035 in a representative experiment). Binding activity for a given peptide was expressed as the O.D. washes, 100 ml of horseradish-peroxidase-conjugated goat anti-mouse F(ab) 2 (Tago, Burlingame, CA) diluted value/cut-off value ( Table 2 ). The omission of either the core particles or the monoclonal anti-HBc resulted in O.D. values 1/10,000 in the same buffer was added. Plates were incubated for 30 min at 37Њ, washed three times, and a mixbelow the cut-off value for all BSA-coupled peptides. Pre-S domains: Peptides L1, L2, and L3 covering the ture of hydrogen peroxide/o-phenylenediamine was added and left for 30 min in the dark at room temperature.
85 N-terminal amino acids (80%) of pre-S1, as well as peptide L5 (all 55 amino acids of pre-S2), did not bind Color development was stopped with 2 N H 2 SO 4 and the optical density was read at 492 nm. Preliminary results to HBV core particles in both assays. Peptide L4, corresponding to the 23 C-terminal amino acids of pre-S1, obtained with the ''L'' peptides prompted us to synthesize two additional peptides, L4a and L4b, overlapping pepwas found to bind to HBV core particles in the inhibition immunoassay (Table 1) . Peptide L4b corresponding to tide L4. Reduction in the signal was quantified as a percentage of inhibition: 100X(1-[OD with peptide/OD withthe 13 C-terminal amino acids of pre-S1 plus the 8 Nterminal amino acids of pre-S2 bound efficiently to HBV out peptide]) and correlated with increasing peptide concentration. The mean percentages of inhibition obtained core particles in the inhibition immunoassay, whereas peptide L4a had only weak binding affinity. In addition, in four independent experiments with the nine peptides at three different concentrations (5, 50, and 100 mg/ml) peptide L4b was the only ''L'' peptide that bound to HBV core particles in the direct binding assay (Table 2) . were determined (Table 1) .
We further tested the peptides ability to bind directly to These results suggest that the 13 C-terminal amino acids of pre-S1 are involved in HBV envelope -core in-HBV core particles by an alternative method based on peptide immobilization to the solid matrix. The direct immobiliteraction. Recently, Dyson and Murray (20) tested random hexazation of free peptides to the ELISA plate resulted in a complete loss of binding activity for all peptides. However, peptides for their binding properties to recombinant HBV core particles. Selected hexapeptides were further inveswhen peptides were conjugated to bovine serum albumin (BSA) with carbodiimide as previously described (19) , a tigated and a peptide LDPAFR equivalent to positions 19 to 24 of pre-S1 inhibited the binding of HBV cores to the reproducible HBV core binding activity was obtained with peptides L4b and S2: Dynatech ELISA plates were coated L polypeptide. In contrast, our L1 peptide (aa 1-28 of pre-S1) containing this 6 amino acids sequence did not with the different peptides coupled to BSA (or with BSA alone) at a concentration of 20 mg/ml in 0.05 M bicarbonate bind to HBV core particles in our assays. This discrepancy may be due to the different lengths of the peptides buffer (pH 9.6) for 24 hr at 4Њ (200 ml per well). Plates were Note. The binding was evaluated as the peptides ability to inhibit core particle capture and detection in a specific immunoassay. OD values given by core particles alone (standardized to 2.5) were compared with OD values for core particles preincubated with various concentrations of a peptide. Results were expressed as percentages of inhibition: 100 1 (1-[OD with peptide/OD without peptide]). Values reported here represent the mean percentages and standard deviations of 4 independent experiments performed with the 9 peptides at 3 concentrations (5, 50, and 100 mg/ml). 0, no inhibition. or to the different origins of the HBV core particles: reDeletions in the cytosolic loop of S hamper particle assembly and secretion (26) . In vitro peptide/core binding combinant Escherichia coli-derived HBV core particles were used in the previous study, whereas we used huassays are thus very convenient alternatives to cell culture for exploring the function of this HBV envelope proman liver-derived HBV core particles. Our results are consistent with the data reported by Bruss and Thomstein using deletion mutants. We could not, however, investigate the potential core binding affinity of the type I sen (7), who tested deletion mutants for their ability to support virion maturation. They showed that the 17 Csignal, also exposed at the cytosolic side of ER in the ipre-S form of L, because the peptide covering this doterminal amino acids of pre-S1 play a key role in virion morphogenesis. Our study suggests that the 13 C-termimain was too hydrophobic to be solubilized in the conditions used in our assays. nal amino acids of pre-S1 (PLSPPLRNTHPQA) are a target for HBV core particles during virion maturation. Inter-
In conclusion, our data suggest that both pre-S1 and S domains of HBV envelope proteins have binding affiniestingly, 8 (62%) of these 13 amino acids are identical (PPTPPLRDTHPHL) in the woodchuck hepatitis virus ties to HBV core particles in vitro. This dual interaction of the HBV core with HBV envelope protein domains may (WHV) L protein (21) , which is able to replace the HBV L protein in HBV maturation (22). The pre-S2 domain, as be required for the virion morphogenesis. represented by the L5 peptide, did not show any binding affinity to HBV core particles. ACKNOWLEDGMENTS S domains: Peptide S1 (amino acids 31 to 55 of the We are indebted to Dr Françoise Aubrit (Diagnostics Transfusion, cytosolic loop of S) did not bind to HBV core particles. sis. This may explain why HBV virions lacking C-terminal pre-S1 sequences have been observed in sera of some patients (23) . Possibly S domain interaction with the HBV
